QQQ   293.78 (-0.29%)
AAPL   142.59 (-1.18%)
MSFT   246.18 (-0.66%)
META   149.53 (+0.38%)
GOOGL   98.20 (-0.65%)
AMZN   102.04 (-1.06%)
TSLA   172.15 (-0.62%)
NVDA   200.85 (+2.80%)
NIO   11.70 (-3.07%)
BABA   110.69 (+0.44%)
AMD   80.71 (+7.40%)
T   20.36 (-0.05%)
MU   61.03 (+1.21%)
F   13.60 (+0.67%)
CGC   2.94 (-2.97%)
GE   81.34 (+1.07%)
DIS   107.90 (-0.54%)
AMC   5.39 (+0.75%)
PFE   43.58 (-1.31%)
PYPL   80.93 (-0.69%)
NFLX   356.79 (+0.83%)
QQQ   293.78 (-0.29%)
AAPL   142.59 (-1.18%)
MSFT   246.18 (-0.66%)
META   149.53 (+0.38%)
GOOGL   98.20 (-0.65%)
AMZN   102.04 (-1.06%)
TSLA   172.15 (-0.62%)
NVDA   200.85 (+2.80%)
NIO   11.70 (-3.07%)
BABA   110.69 (+0.44%)
AMD   80.71 (+7.40%)
T   20.36 (-0.05%)
MU   61.03 (+1.21%)
F   13.60 (+0.67%)
CGC   2.94 (-2.97%)
GE   81.34 (+1.07%)
DIS   107.90 (-0.54%)
AMC   5.39 (+0.75%)
PFE   43.58 (-1.31%)
PYPL   80.93 (-0.69%)
NFLX   356.79 (+0.83%)
QQQ   293.78 (-0.29%)
AAPL   142.59 (-1.18%)
MSFT   246.18 (-0.66%)
META   149.53 (+0.38%)
GOOGL   98.20 (-0.65%)
AMZN   102.04 (-1.06%)
TSLA   172.15 (-0.62%)
NVDA   200.85 (+2.80%)
NIO   11.70 (-3.07%)
BABA   110.69 (+0.44%)
AMD   80.71 (+7.40%)
T   20.36 (-0.05%)
MU   61.03 (+1.21%)
F   13.60 (+0.67%)
CGC   2.94 (-2.97%)
GE   81.34 (+1.07%)
DIS   107.90 (-0.54%)
AMC   5.39 (+0.75%)
PFE   43.58 (-1.31%)
PYPL   80.93 (-0.69%)
NFLX   356.79 (+0.83%)
QQQ   293.78 (-0.29%)
AAPL   142.59 (-1.18%)
MSFT   246.18 (-0.66%)
META   149.53 (+0.38%)
GOOGL   98.20 (-0.65%)
AMZN   102.04 (-1.06%)
TSLA   172.15 (-0.62%)
NVDA   200.85 (+2.80%)
NIO   11.70 (-3.07%)
BABA   110.69 (+0.44%)
AMD   80.71 (+7.40%)
T   20.36 (-0.05%)
MU   61.03 (+1.21%)
F   13.60 (+0.67%)
CGC   2.94 (-2.97%)
GE   81.34 (+1.07%)
DIS   107.90 (-0.54%)
AMC   5.39 (+0.75%)
PFE   43.58 (-1.31%)
PYPL   80.93 (-0.69%)
NFLX   356.79 (+0.83%)
NYSE:BDX

Becton, Dickinson and - BDX Stock Forecast, Price & News

$253.78
+1.56 (+0.62%)
(As of 02/1/2023 10:57 AM ET)
Add
Compare
Today's Range
$251.79
$254.58
50-Day Range
$237.34
$259.34
52-Week Range
$215.90
$280.62
Volume
132,917 shs
Average Volume
1.06 million shs
Market Capitalization
$72.14 billion
P/E Ratio
43.16
Dividend Yield
1.46%
Price Target
$273.82

Becton, Dickinson and MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.63 Rating Score
Upside/​Downside
7.9% Upside
$273.82 Price Target
Short Interest
Healthy
0.70% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.25
Upright™ Environmental Score
News Sentiment
0.39mentions of Becton, Dickinson and in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.73%
From $11.94 to $13.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

26th out of 1,053 stocks

Surgical & Medical Instruments Industry

3rd out of 105 stocks


BDX stock logo

About Becton, Dickinson and (NYSE:BDX) Stock

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Receive BDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Becton, Dickinson and and its competitors with MarketBeat's FREE daily newsletter.

BDX Stock News Headlines

Move Over Lithium – 220 Pounds of Graphite In Every EV Battery
Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska.
Becton, Dickinson and (BDX) Set to Announce Earnings on Thursday
BD Publishes 2022 Cybersecurity Annual Report
Huge Upside Potential With "Staggering" Solar Demand
Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth.
Becton, Dickinson declares $0.91 dividend
Becton Dickinson Reaches New 52-Week High (BDX)
Becton, Dickinson And (NYSE: BDX)
What 6 Analyst Ratings Have To Say About Becton, Dickinson
Michelle Quinn Named Acting General Counsel for BD
BofA Securities Upgrades Becton Dickinson to Buy
See More Headlines
Receive BDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Becton, Dickinson and and its competitors with MarketBeat's FREE daily newsletter.

BDX Company Calendar

Last Earnings
11/10/2022
Ex-Dividend for 12/30 Dividend
12/08/2022
Dividend Payable
12/30/2022
Today
2/01/2023
Next Earnings (Confirmed)
2/02/2023
Ex-Dividend for 3/31 Dividend
3/09/2023
Dividend Payable
3/31/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07588710
Employees
77,000
Year Founded
1897

Price Target and Rating

Average Stock Price Forecast
$273.82
High Stock Price Forecast
$310.00
Low Stock Price Forecast
$245.00
Forecasted Upside/Downside
+7.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

Net Income
$1.78 billion
Pretax Margin
9.45%

Debt

Sales & Book Value

Annual Sales
$18.87 billion
Cash Flow
$19.86 per share
Book Value
$88.64 per share

Miscellaneous

Free Float
283,387,000
Market Cap
$72.14 billion
Optionable
Optionable
Beta
0.58

Social Links


Key Executives

  • Thomas E. PolenThomas E. Polen
    Chairman, President & Chief Executive Officer
  • Christopher J. DelOreficeChristopher J. DelOrefice
    Chief Financial Officer & Executive Vice President
  • William R. Sigmund
    Chief Medical Officer & Executive Vice President
  • Elizabeth McCombs
    Chief Technology Officer & Executive VP
  • Joseph M. Smith
    Chief Scientific Officer & Senior Vice President













BDX Stock - Frequently Asked Questions

Should I buy or sell Becton, Dickinson and stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BDX shares.
View BDX analyst ratings
or view top-rated stocks.

What is Becton, Dickinson and's stock price forecast for 2023?

8 Wall Street analysts have issued 1 year price objectives for Becton, Dickinson and's shares. Their BDX share price forecasts range from $245.00 to $310.00. On average, they anticipate the company's share price to reach $273.82 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.
View analysts price targets for BDX
or view top-rated stocks among Wall Street analysts.

How have BDX shares performed in 2023?

Becton, Dickinson and's stock was trading at $254.30 on January 1st, 2023. Since then, BDX shares have decreased by 0.8% and is now trading at $252.22.
View the best growth stocks for 2023 here
.

Are investors shorting Becton, Dickinson and?

Becton, Dickinson and saw a drop in short interest in January. As of January 15th, there was short interest totaling 1,990,000 shares, a drop of 20.7% from the December 31st total of 2,510,000 shares. Based on an average daily volume of 1,450,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.7% of the company's stock are short sold.
View Becton, Dickinson and's Short Interest
.

When is Becton, Dickinson and's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our BDX earnings forecast
.

How can I listen to Becton, Dickinson and's earnings call?

Becton, Dickinson and will be holding an earnings conference call on Thursday, February 2nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Becton, Dickinson and's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) released its quarterly earnings data on Thursday, November, 10th. The medical instruments supplier reported $2.75 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.02. The medical instruments supplier earned $4.76 billion during the quarter, compared to the consensus estimate of $4.72 billion. Becton, Dickinson and had a net margin of 9.16% and a trailing twelve-month return on equity of 14.47%. The company's quarterly revenue was down 6.6% on a year-over-year basis. During the same period in the prior year, the company earned $2.15 earnings per share.
Read the conference call transcript
.

How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?

Becton, Dickinson and announced a quarterly dividend on Tuesday, January 24th. Investors of record on Friday, March 10th will be paid a dividend of $0.91 per share on Friday, March 31st. This represents a $3.64 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Thursday, March 9th.
Read our dividend analysis for BDX
.

Is Becton, Dickinson and a good dividend stock?

Becton, Dickinson and (NYSE:BDX) pays an annual dividend of $3.64 per share and currently has a dividend yield of 1.45%. The company has been increasing its dividend for 51 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 61.90%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BDX will have a dividend payout ratio of 27.39% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BDX.

How will Becton, Dickinson and's stock buyback program work?

Becton, Dickinson and declared that its Board of Directors has initiated a stock buyback program on Thursday, November 4th 2021, which permits the company to buyback 10,000,000 outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its stock is undervalued.

What guidance has Becton, Dickinson and issued on next quarter's earnings?

Becton, Dickinson and issued an update on its FY 2022 earnings guidance on Saturday, December, 10th. The company provided earnings per share guidance of $11.85-$12.10 for the period, compared to the consensus estimate of $12.19. The company issued revenue guidance of $18.60 billion-$18.80 billion, compared to the consensus revenue estimate of $19.37 billion.

What is Tom Polen's approval rating as Becton, Dickinson and's CEO?

136 employees have rated Becton, Dickinson and Chief Executive Officer Tom Polen on Glassdoor.com. Tom Polen has an approval rating of 91% among the company's employees. This puts Tom Polen in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Becton, Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton, Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Walt Disney (DIS), Abbott Laboratories (ABT), Intel (INTC), Verizon Communications (VZ), Cisco Systems (CSCO) and CVS Health (CVS).

What is Becton, Dickinson and's stock symbol?

Becton, Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton, Dickinson and's major shareholders?

Becton, Dickinson and's stock is owned by a number of institutional and retail investors. Top institutional investors include Parnassus Investments LLC (1.03%), Troy Asset Management Ltd (0.32%), Sumitomo Mitsui Trust Holdings Inc. (0.30%), M&G Investment Management Ltd. (0.22%), New York State Common Retirement Fund (0.21%) and Kovitz Investment Group Partners LLC (0.18%). Insiders that own company stock include Alexandre Conroy, Betty D Larson, Claire Fraser, David Hickey, James C Lim, Patrick Kaltenbach, Rebecca W Rimel, Rebecca W Rimel, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Thomas J Spoerel and Thomas J Spoerel.
View institutional ownership trends
.

How do I buy shares of Becton, Dickinson and?

Shares of BDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Becton, Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $252.22.

How much money does Becton, Dickinson and make?

Becton, Dickinson and (NYSE:BDX) has a market capitalization of $71.70 billion and generates $18.87 billion in revenue each year. The medical instruments supplier earns $1.78 billion in net income (profit) each year or $5.88 on an earnings per share basis.

How many employees does Becton, Dickinson and have?

The company employs 77,000 workers across the globe.

Does Becton, Dickinson and have any subsidiaries?
The following companies are subsidiares of Becton, Dickinson and: Accuri Cytometers, Accuri Cytometers Inc., Alverix Inc, Alverix Inc., Atto Bioscience Inc, BD Holding S. de R.L. de C.V., BD Infection Prevention BV, BD Kiestra BV, BD Kiestra Total Lab Automation, BD Rapid Diagnostic (Suzhou) Co. Ltd., BD San Luis Potosi S.A. de C.V., BD Switzerland Sarl, BD Ventures LLC, BD West Africa Limited, BDX INO LLC, Bard (Thailand) Limited, Bard ASDI Inc., Bard Access Systems Inc., Bard Acquisition Sub Inc., Bard Australia Pty. Limited, Bard Benelux N.V., Bard Brachytherapy Inc., Bard Brasil Indústria e Comércio de Produtos Para a Saúde Ltda., Bard Canada Inc., Bard Chile S.p.A., Bard Czech Republic s.r.o., Bard Devices Inc., Bard Dublin ITC Limited, Bard EMEA Finance Center Sp.z o.o., Bard European Distribution Center N.V., Bard Finance B.V. & Co. KG., Bard Financial Services Ltd., Bard Finland OY, Bard France S.A.S., Bard Global Holdings I LLC, Bard Global Holdings II LLC, Bard Global Holdings III LLC, Bard Healthcare Inc., Bard Healthcare Science (Shanghai) Limited, Bard Hellas S.A., Bard Holding SAS, Bard Holdings Limited, Bard Holdings Netherlands B.V., Bard Hong Kong Limited, Bard IP Holdings Inc., Bard India Healthcare Pvt. Ltd., Bard International Holdings B.V., Bard International Inc., Bard Istanbul Healthcare Limited Company, Bard Korea Ltd., Bard Limited, Bard MRL Acquisition Corp., Bard Malaysia Healthcare Sdn. Bhd., Bard Medica SA, Bard Medical Devices (Beijing) Co. Ltd., Bard Medical R&D (Shanghai) Co. Ltd., Bard Medical SA (Proprietary) Limited, Bard Mexico Realty S. de R.L. de C.V., Bard Norden AB, Bard Norway AS, Bard Pacific Health Care Company Ltd., Bard Peripheral Vascular Inc., Bard Poland Sp. z.o.o., Bard Productos Plasticos e Medicos Ltda., Bard Reynosa S.A. de C.V., Bard S.r.l., Bard Sdn. Bhd., Bard Shannon Limited, Bard Singapore Private Limited, Bard Sourcing Office Singapore Pte. Ltd., Bard Sweden AB, Bard UK Newco Limited, Bard de Espana S.A., Becton Dickinson (Gibraltar) Holdings Ltd., Becton Dickinson (Gibraltar) Limited, Becton Dickinson (Gibraltar) Management Limited, Becton Dickinson (Mauritius) Limited, Becton Dickinson (Pty) Ltd., Becton Dickinson (Thailand) Limited, Becton Dickinson A.G., Becton Dickinson A/S, Becton Dickinson Argentina S.R.L., Becton Dickinson Asia Holdings Ltd., Becton Dickinson Asia Limited, Becton Dickinson Austria GmbH, Becton Dickinson Austria Holdings GmbH, Becton Dickinson B.V., Becton Dickinson B.V. Saudi Limited Company, Becton Dickinson Benelux N.V., Becton Dickinson Biosciences Systems and Reagents Inc., Becton Dickinson Canada Inc., Becton Dickinson Caribe Ltd., Becton Dickinson Croatia d.o.o., Becton Dickinson Czechia s.r.o., Becton Dickinson Dispensing Belgium BVBA, Becton Dickinson Dispensing Denmark A/S, Becton Dickinson Dispensing France SAS, Becton Dickinson Dispensing Ireland Limited, Becton Dickinson Dispensing Norway, Becton Dickinson Dispensing Spain S.L.U., Becton Dickinson Dispensing UK Ltd., Becton Dickinson Distribution Center N.V., Becton Dickinson East Africa Ltd., Becton Dickinson Euro Finance Sarl, Becton Dickinson Europe Holdings S.A.S., Becton Dickinson France S.A.S., Becton Dickinson GSA Beteilgungs GmbH, Becton Dickinson Global Holdings I Inc., Becton Dickinson Global Holdings II LLC, Becton Dickinson Global Holdings IV LLC, Becton Dickinson Global Holdings V LLC, Becton Dickinson Global Holdings VII LLC, Becton Dickinson Global Holdings VIII LLC, Becton Dickinson Global Services Centre Sdn. Bhd, Becton Dickinson GmbH, Becton Dickinson Guatemala S.A., Becton Dickinson Hellas S.A., Becton Dickinson Holdings Limited, Becton Dickinson Holdings Ltd., Becton Dickinson Holdings Pte Ltd., Becton Dickinson Hungary Kft., Becton Dickinson India Private Limited, Becton Dickinson Industrias Cirurgicas Ltda., Becton Dickinson Infusion Therapy AB, Becton Dickinson Infusion Therapy Holdings UK Limited, Becton Dickinson Infusion Therapy Systems Inc., Becton Dickinson Infusion Therapy Systems Inc. S.A. de C.V., Becton Dickinson Infusion Therapy UK, Becton Dickinson Insulin Syringe Ltd., Becton Dickinson International Holdings II Pte Ltd., Becton Dickinson International Holdings III Pte Ltd., Becton Dickinson International Holdings Pte Ltd., Becton Dickinson Israel Ltd., Becton Dickinson Italia S.p.A., Becton Dickinson Ithalat Ihracat Limited Sirketi, Becton Dickinson Korea Holding Inc., Becton Dickinson Korea Ltd., Becton Dickinson Ltd., Becton Dickinson Luxembourg Finance S.a.r.L., Becton Dickinson Luxembourg Global Holdings Sarl, Becton Dickinson Luxembourg Holdings II S.a.r.L, Becton Dickinson Luxembourg Holdings III S.a.r.L, Becton Dickinson Luxembourg Holdings V S.a.r.L., Becton Dickinson Malaysia Inc., Becton Dickinson Management GmbH & Co. KG, Becton Dickinson Matrex Holdings Inc., Becton Dickinson Medical (S) Pte Ltd., Becton Dickinson Medical Devices (Shanghai) Co. Ltd., Becton Dickinson Medical Devices (Suzhou) Co. Ltd., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson Medical Technology (Jiangsu) Co. Ltd., Becton Dickinson Netherlands Global Holdings II C.V., Becton Dickinson Netherlands Holdings B.V., Becton Dickinson Netherlands Holdings II B.V., Becton Dickinson Norway AS, Becton Dickinson O.Y., Becton Dickinson Overseas Services Ltd., Becton Dickinson Pakistan (Pvt) Ltd., Becton Dickinson Penel Limited, Becton Dickinson Philippines Inc., Becton Dickinson Polska Sp.z.o.o., Becton Dickinson Portugal Unipessoal Lda., Becton Dickinson Pty. Ltd., Becton Dickinson Research Centre Ireland Limited, Becton Dickinson Rowa Germany GmbH, Becton Dickinson Rowa Italy Srl, Becton Dickinson S.A., Becton Dickinson Sample Collection GmbH, Becton Dickinson Scot Financing L.L.P., Becton Dickinson Scot Financing L.P., Becton Dickinson Sdn. Bhd., Becton Dickinson Slovakia s.r.o., Becton Dickinson Sweden AB, Becton Dickinson Sweden Holdings AB, Becton Dickinson Switzerland Global Holdings SarL, Becton Dickinson Technology Campus India, Becton Dickinson U.K. Limited, Becton Dickinson UK Financing I Limited, Becton Dickinson UK Financing II Limited, Becton Dickinson Venezuela C.A., Becton Dickinson Venture LLC, Becton Dickinson Verwaltungs GmbH, Becton Dickinson Vostok LLC, Becton Dickinson Worldwide Investments Sa.r.L., Becton Dickinson Zambia Limited, Becton Dickinson and Company Ltd., Becton Dickinson de Colombia Ltda., Becton Dickinson de Mexico S.A. de C.V., Becton Dickinson del Uruguay S.A., Bee IT Solutions, Benex Ltd., Biometric Imaging, Bridger Biomed Inc., C. R. Bard (Portugal) - Produtos e Artigos Medicos e Farmaceuticos, C. R. Bard Do Brasil Productos Medicos Ltda., C. R. Bard GmbH, C. R. Bard Inc., C. R. Bard Netherlands Sales B.V., C.R. Bard Inc, CME America LLC, CME Ltd., CME Medical (UK) Limited, CME UK (Holdings) Limited, CRISI Medical Systems, CRISI Medical Systems Inc., Caesarea Medical Electronics, Cardal II LLC, Care Fusion Development Private Limited, CareFusion (Barbados) SrL, CareFusion (Shanghai) Commercial and Trading Co. Limited, CareFusion 213 LLC, CareFusion 2200 Inc., CareFusion 2201 Inc., CareFusion 302 LLC, CareFusion 303 Inc., CareFusion Asia (HK) Limited, CareFusion Corporation, CareFusion Corporation., CareFusion D.R. 203 Ltd., CareFusion France 309 S.A.S., CareFusion Israel 330 Ltd., CareFusion Italy 312 S.p.A., CareFusion Manufacturing LLC, CareFusion Mexico 215 S.A. de C.V., CareFusion Netherlands 328 B.V., CareFusion Netherlands 503 B.V., CareFusion Netherlands 504 B.V., CareFusion Netherlands Financing 283 C.V., CareFusion Resources LLC, CareFusion S.A. 319 (Proprietary) Limited, CareFusion Solutions LLC, CareFusion U.K. 244 Limited, CareFusion U.K. 305 Limited, CareFusion U.K. 306 Limited, Carmel Pharma AB, Carmel Pharma Inc, Cato Software Solutions, Cell Analysis Systems Inc, Cellular Research, Cellular Research Inc., Clearstream Technologies Group Limited, Clearstream Technologies Limited, Clontech Laboratories Inc, Corporativo BD de Mexico S. de R.L. de C.V., Critical Device Corporation, Cubex, Cytognos, Cytopeia Inc, DLD (Bermuda) Ltd., DVL Acquisition Sub Inc., Davol Inc., Davol International Limited, Davol Surgical Innovations S.A. de C.V., Difco Laboratories Incorporated, Distribuidora BD Mexico S.A. de C.V., Dutch American Manufacturers (D.A.M.) B.V., Dymax Corporation, Embo Medical Limited, Enturia de Mexico S. de R.L. de C.V., Enturican Inc., FJ International Inc., FlowCardia Inc., FlowCardia LLC, FlowJo LLC, Franklin Lakes Enterprises L.L.C., GSL Solutions, Gamer Lasertechnik GmbH, GenCell Biosystems, GenCell Biosystems Ltd., GeneOhm Sciences Canada ULC, GeneOhm Sciences Inc, Gentest Corporation, Gesco International Inc., Gesco International LLC, Glentech Inc, HandyLab Inc, HandyLab Inc., IBD Holdings LLC, Iontophoretics Corporation, JoHome LLC, Kabushiki Kaisha Medicon (Medicon Inc.), Liberator Health and Education Services Inc., Liberator Health and Wellness Inc., Liberator Medical Holdings Inc., Liberator Medical Supply Inc., Limited Liability Company Bard Rus, Loma Vista Medical Inc., Loma Vista Medical LLC, Luther Medical Products Inc, Lutonix Inc., Med-Design Corporation, Med-Design Investment Holdings Inc., Med-Safe Systems Inc, Med-Safe Systems Inc., MedChem Products Inc., Medafor Inc., Medegen LLC, Medinservice.com Inc., Medivance Inc., NAT Diagnostics Inc., NAT Diagnostics Inc., NOW Medical Distribution Inc., NOW Medical Distribution LLC, Navarre Biomedical LLC, Navarre Biomedical Ltd., Neomend Inc., Nippon Becton Dickinson Company Ltd., Omega Biosystems Incorporated, P.R.C. (Isialys) Societe a responsabilitie limitee, PT Becton Dickinson Indonesia, PharMingen, PharMingen., Plasso Technology Ltd, PreAnalytiX GmbH, Pristine Access Technologies Inc., ProSeed Inc., Procesos para Esterilizacion S.A. de C.V., Productos Bard de Mexico S.A. de C.V., Productos Para el Cuidado de la Salud S.A. de C.V., Puls Medical Devices AS LC, PureWick Corporation, Roberts Laboratories Inc., Rochester Medical Corporation, Rochester Medical Ltd., Saf-T-Med Inc, Safety Syringes Inc., Scanwell Health Inc., Sendal S.L.U., SenoRx Inc., SenoRx LLC, Shield Healthcare Centers Inc., Sirigen Group Limited, Sirigen II Limited, Sirigen Inc., Sistemas Médicos ALARIS S.A. de C.V., Specialized Cooperative Corporation, Specialized Health Products Inc., Specialized Health Products International Inc., Specialized Health Products International LLC, Staged Diabetes Management LLC, Straub Medical AG, Straub Medical AG, Surgical Site Solutions Inc., TVA Medical Inc, TVA Medical Inc., Tepha Inc, Tepha Inc., Tissuemed Ltd., Tri-County Medical & Ostomy Supplies Inc., TriPath Imaging Inc., Tru-Fit Marketing Corporation, Vas-Cath Incorporated, Vascular Pathways Inc., Velano Vascular, Velano Vascular Inc., Venclose Inc., Venetec International Inc., Venetec International LLC, Visitec, Y-Med Inc., Y-Med LLC, and ZebraSci Inc..
Read More
How can I contact Becton, Dickinson and?

Becton, Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The official website for the company is www.bd.com. The medical instruments supplier can be reached via phone at (201) 847-6800 or via fax at 201-847-6475.

This page (NYSE:BDX) was last updated on 2/1/2023 by MarketBeat.com Staff